Otonomy to Present at Cowen and Company Health Care Conference

Back to Jobs

SAN DIEGO , March 06, 2018 (GLOBE NEWSWIRE) — Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber , Ph.D., president and chief executive officer, will present at the 38th Annual Cowen and

Apply Now